Robert Getzenberg

Robert Getzenberg

Company: Astellas Pharmaceuticals

Job title: Medical Director, Diagnostics, Oncology


Claudin18.2 Identifies a Previously Undefined Patient Population with Gastric/GEJ Cancer 11:30 am

Claudin 18.2 is a tight junction protein that during transformation is retained and exposed for detection Claudin 18.2 can be detected by IHC and is prevalent in a significant percentage of patients  The biomarker Claudin 18.2 may guide treatment decisions in these patientsRead more

day: Day 2 Track B AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.